MedTrace Logo

Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell Lymphoma

NCT04231734 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-08-28

No results posted yet for this study

Summary

This study evaluates adherence to a ketogenic diet in patients with low tumor burden, treatment-naïve mantle cell lymphoma.

Conditions

Interventions

OTHER

Ketogenic Diet

Prepared ketogenic meals, 3 per day for up to 12 weeks (Day 1 through Day 84)

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Peter Martin, M.D. · Weill Medical College of Cornell University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2026-04-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04231734 on ClinicalTrials.gov